The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Open accessAbstract
The kinetics of inhibition of four hemostatic system enzymes by antithrombin were examined as a function of heparin concentration. Plots of the initial velocity of factor Xa-antithrombin or plasmin-antithrombin interaction versus the level of added mucopolysaccharide exhibit an ascending limb and subsequent plateau regions. In each case, the kinetic profile is closely correlated with the concentration of the heparin . antithrombin complex formed within the reaction mixture. A decrease in the velocity of inhibition is not observed at high levels of added mucopolysaccharide despite the generation of significant quantities of heparin-enzyme interaction products. The second-order rate constants for the neutralization of factor Xa or plasmin by the mucopolysaccharide . inhibitor complex are 2.4 x 10(8) M-1 min-1 and 4.0 x 10(6) M-1 min-1, respectively. These parameters must be contrasted with the similarly designated constants obtained in the absence of heparin which are 1.88 x 10(5) M-1 min-1 and 4.0 x 10(4) M-1 min-1, respectively. Plots of the initial velocity of the factor IXa-antithrombin or the thrombin-antithrombin interaction versus the level of added mucopolysaccharide exhibit an ascending limb, pseudoplateau, descending limb, and final plateau regions. In each case, the ascending limb and pseudoplateau are closely correlated with the concentration of heparin c antithrombin complex formed within the reaction mixture. Furthermore, the descending limb and final plateau of these two processes coincide with the generation of increasing amounts of the respective mucopolysaccharide-enzyme interaction products. The second-order rate constants for the neutralization of factor IXa or thrombin by the heparin . antithrombin complex are 3.0 x 10(8) M-1 min-1 and 1.7 x 10(9) M-1 min-1, respectively. The second-order rate constants for the inhibition of mucopolysaccharide-factor IXa or mucopolysaccharide-thrombin interaction products by the heparin . antithrombin complex are 2.0 x 10(7) M-1 min-1 and 3.0 x 10(8) M-1 min-1, respectively. These kinetic parameters must be contrasted with similarly designated constants obtained in the absence of mucopolysaccharide which are 2.94 x 10(4) M-1 min-1 and 4.25 x 10(5) M-1 min-1, respectively. Thus, our data demonstrate that binding of heparin to antithrombin is required for the mucopolysaccharide-dependent enhancement in the rates of neutralization of thrombin, factor IXa, factor Xa, or plasmin by the protease inhibitor. Furthermore, a careful comparison of the various constants suggests that the direct interaction between heparin and antithrombin may be largely responsible for the kinetic effect of this mucopolysaccharide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor
Rosenberg, R. D., & Damus, P. S. (1973) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)43472-8 · Cited by 1,356
Self-citationCorrelation between structure and function of heparin
Rosenberg, R. D., & Lam, L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.3.1218 · Cited by 281
Self-citationFractionation of low molecular weight heparin species and their interaction with antithrombin.
Beeler, D., Rosenberg, R., & Jordan, R. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30159-x · Cited by 208
Self-citationJordan, F., Patrick, J., & Salamone, S. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30233-8 · Cited by 118
The binding of low molecular weight heparin to hemostatic enzymes.
Jordan, R. E., Oosta, G. M., Gardner, W. T., & ROSENBERG, R. D. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)70430-x · Cited by 107
Self-citationHighly active heparin species with multiple binding sites for antithrombin
ROSENBERG, R. D., Jordan, R. E., Favreau, L. V., & Lam, L. H. (1979) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(79)90260-2 · Cited by 85
Self-citationHeparin reacts stoichiometrically with thrombin during thrombin inhibition in human plasma
Smith, G. F., & Craft, T. J. (1976) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(76)90893-7 · Cited by 21
Cited by
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Hirsh, J., & Levine, M. (1992) · Blood · doi:10.1182/blood.v79.1.1.bloodjournal7911 · Cited by 894
Hirsh, J., Bauer, K. A., Donati, M. B., Gould, M., Samama, M. M., & Weitz, J. I. (2008) · Chest · doi:10.1378/chest.08-0689 · Cited by 755
Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V. (2001) · Circulation · doi:10.1161/01.cir.103.24.2994 · Cited by 565
Metadata
- Authors
- Jordan, R. E., Oosta, G. M., Gardner, W. T., & Rosenberg, R. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1980-11
- Volume
- 255
- Issue
- 21
- Pages
- 10081-10090
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1524312435
- Cited by
- 333
- References
- 7
- FWCI
- 9.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. https://app.cochat.ai/papers/10.1016/s0021-9258(19)70431-1
- The paper
- Jordan, R. E., Oosta, G. M., Gardner, W. T., & Rosenberg, R. D. (1980). The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. Journal of Biological Chemistry. https://doi.org/10.1016/s0021-9258(19)70431-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.